Projects Funded

2011

OsteoGeneX, Kansas City, Kan.
The KBA awarded $500,000 to OsteoGeneX to support the selection of lead drug candidates for its groundbreaking approach to stopping the advance of osteoporosis and related bone disorders. The company is in the entry phase of international intellectual property protection. (7/27/2010).

Expected or Realized Outcomes: Projected $2.0M in equity investment from angel investors. Women’s Capital Connection members along with a new and original angel have invested approximately $305,000 in the current convertible note round. Future patent prospects.

University of Kansas Cancer Center , Kansas City, Kan.
The KBA awarded $780,000 over three years  to the University of Kansas Cancer Center upon the successful attraction of Dr. Liang Xu to the cancer center and the university’s Department of Molecular Biosciences. Xu, a University of Michigan Medical Center faculty member, would be designated a KBA rising star scholar in Kansas for his work on molecular cell signaling and nanotechnology. (7/27/2010).

Expected or Realized Outcomes: NCI grant funding of approximately $700,000 and a projection of $3,526,000 in federal research funding over the next 10 years. One realized job with his hiring and lab personnel budgeted in the future. Creation of start-up companies, commercialization of products, and patents.

University of Kansas Cancer Center , Kansas City, Kan.
The KBA awarded  $850,000 over five years to the University of Kansas Cancer Center upon the successful attraction of Dr. Daotai Nie to the cancer center and the KU School of Medicine’s Department of Molecular and Integrative Physiology. Nie, a faculty member at the Southern Illinois University School of Medicine, would be designated a KBA rising star scholar for his work on molecular mechanisms of cancer cell growth and cancer drug development. (7/27/2010).

Expected or Realized Outcomes: Research funding of $1,409,000 (NCI and DOD grants) with a projection of $3,930,000 in federal research funding over the next 10 years. One realized job with his hiring and lab personnel budgeted in the future. Creation of start-up companies, commercialization of products, and patents.